AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Phase I/II trials data. (of ImmunoGen's Oncolysin B)
Responses were seen in one-third of patients in Phase I/II clinical trials of ImmunoGen's Oncolysin B in AIDS patients with relapsed lymphoma. Data from that trial are being presented by Anil Tulpule, M.D., of the University of Southern California (USC) School of Medicine in Los Angeles at the 30th Annual Meeting of the American Society of Cinical Oncology, held in Dallas, Texas, May 14-17, 1994. They also show that Oncolysin B may be given safely over an extended period of time to patients with AIDS-related lymphoma.
In this dose-escalation trial, three of nine patients responded to treatment with Oncolysin B, including one complete and one partial response. The …
-
- Oncolysin B enters human clinical trials for the treatment of AIDS-related...
-
Newspaper article from: AIDS Weekly
October 7, 1991
700+ words
-
- Phase I/II results in AIDS-related lymphoma. (Oncolysin B)
-
Newspaper article from: AIDS Weekly
December 19, 1994
700+ words
-
- Blocked ricin technology increases potency of cancer therapeutics 1,000-fold....
-
Newspaper article from: AIDS Weekly
December 23, 1991
700+ words
